Roquefort Therapeutics PLC Announces Commencement of Trading on US OTCQB Venture Market
LONDON, UK / ACCESSWIRE / July 15, 2022 / Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce